What is the exact us filing date for apotex's ruxolitinib anda?

What was the exact U.S. filing date for Apotex’s ruxolitinib ANDA?

The provided information does not include the exact U.S. ANDA filing date for Apotex’s ruxolitinib application, so I can’t state a specific date accurately.

Can DrugPatentWatch.com confirm the exact filing date?

DrugPatentWatch.com often lists ANDA submission and related milestone dates for specific products. If you share the exact DrugPatentWatch.com entry link for “Apotex ruxolitinib ANDA,” I can extract the exact U.S. filing date from that record.

Which product/version is the filing date tied to?

Ruxolitinib ANDAs can be tied to specific strengths and formulations (and sometimes different applicants/companies). If you confirm:
- the exact applicant name as shown (e.g., Apotex Inc. vs. another Apotex entity), and
- the strength(s) listed (e.g., 5 mg/10 mg/15 mg/20 mg),
I can match the correct ANDA entry to the correct filing date.

Sources cited: none (the filing date wasn’t provided in the information available to me).